The next Alzheimer’s treatment could come from an unexpected place. In new research released this week, scientists have found ...

We now have two FDA-approved disease-modifying treatments for Alzheimer's disease, and hundreds of clinical trials are ...

The disease afflicts nearly seven million Americans, about one in every nine people over the age of 65, making it a leading ...

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...

Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...

In a trial featuring a mouse model of Alzheimer's, scientists found that inhaling a mixture containing xenon gas helped ...

Vigil Neuroscience reported a strong safety profile and 50% sTREM2 reduction in an early-stage trial for VG-3927, potentially ...

Researchers uncover promising evidence that xenon gas, commonly used in anesthesia, may help reduce brain deterioration and ...

LATE is a prevalent condition in late life and can contribute to memory loss and cognitive decline, according to report ...

New drug approvals and a federal dementia care pilot program among the year's significant developments, according to the ...

A new Alzheimer’s treatment at Hancock Regional Hospital has both doctors and patients feeling cautiously optimistic.

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...